WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'8301 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 14'5521 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 49'066  48'653  48'229  47'792  47'343  40'404  34'272  27'738 
Births 732  739  746  754  761  848  905  881 
Surviving infants 721  727  734  741  747  829  877  837 
Pop. less than 5 years 3'682  3'712  3'738  3'770  3'797  4'152  4'341  3'986 
Pop. less than 15 years 11'520  11'622  11'713  11'805  11'882  12'740  12'465  11'262 
Female 15-49 years 13'300  13'256  13'204  13'147  13'084  11'207  9'018  6'780 

Number of reported cases

(Click for retrospective incidence data for Colombia)
Diphtheria
ChartChart
  11  16 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  12'520  9'222 
Mumps
ChartChart
  17'835  10'452  6'573  7'368  7'884 
Pertussis
ChartChart
  330  536  986  734  13'682  446  1'961  7'664 
Polio*
ChartChart
  129 
Rubella
ChartChart
  157 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10  133 
Tetanus (total)**
ChartChart
  37  45  48  59  31  27  167  593 
Yellow fever
ChartChart
  11 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Colombia)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS   83  91  88  90  89  85  91  95  45 
DTP1 2009  97  DHS   83  94  93  93  91  89  75 
DTP3 2009  90  DHS   83  92  91  91  90  91  79  88  16 
DTP4          86  86  93  90 
IPV1          94  93  92 
HepB_BD          81  87  86  82  82 
HepB3 2009  90  DHS   83  92  91  91  90  91  78 
Hib3 2009  90  DHS   83  92  91  91  90  91  65 
JapEnc         
MCV1          93  93  94  91  92  80  82  13 
MCV2          89  87  86  88  72  84 
MenA         
PCV1          94  91  93  91  89 
PCV2          93  90  91  90  90 
PCV3          91  89  91  89  87 
Pol3 2009  82  DHS   83  92  91  91  90  91  82  93  16 
Rota1          90  90  90  89  86 
RotaC          90  90  91  89  87 
RCV1          93  93  94  91  92 
TT2plus 1994  57  DHS   47  54  58  51  33  33 
PAB          54  79  60 
VAD1         
YFV 2009  77  DHS   83  88  77  54  92  92 
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Colombia)
BCG
ChartChart
  91  88  90  89  85  91  95  45 
DTP1
ChartChart
  94  93  93  91  97  91  96  39 
DTP3
ChartChart
  92  91  91  90  91  79  88  16 
HepB3
ChartChart
  92  91  91  90  91  78 
HepB_BD
  81 
Hib3
ChartChart
  92  91  91  90  91  65 
IPV1
ChartChart
  94  92  92 
MCV1
ChartChart
  93  93  94  91  92  88  82  13 
MCV2
ChartChart
  89  87  86  88  72  84 
PCV3
ChartChart
  91  89  91  89  87 
Pol3
  92  91  91  90  91  82  93  16 
RCV1
ChartChart
  93  93  94  91  92  88 
RotaC
ChartChart
  90  90  91  89  87 
YFV
ChartChart
  88  77  85  92  92 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 1'122  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 59
From 80 to 89% 25
From 50 to 79% 14
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 5 years; children with pertussis contraindication
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepA_Adult Yes applies to victims of sexual violence regardless of the age of the victim applies to victims of sexual violence regardless of the age of the victim
HepA_Pediatric 1 year; Yes
HepB_Adult Yes victims of sexual violence regardless of age
HepB_Pediatric birth; Yes
HPV 9-17 years; +6 months; Yes
Influenza_Adult >=50 years; Yes and adults with chronic illness, pregnant women
Influenza_Pediatric 6-23 months; Yes and children with chronic illness
IPV 2 months; Yes
MenACWY-135 conj 2, 4, 6 months; No in case of outbreak
MMR 1, 5 years; Yes
MR 11-39 years; Yes travellers who request at free demand, susceptible persons in the process of MRCV and BAC
OPV 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rabies Yes pre-exposure 3 doses: day 0, 7, 28; post exposure 5 doses: day 0, 3, 7, 14, 30
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months;+1, +1 years; Yes adults
Tdap Yes for pregnant women in the 26th week of gestation, children who presented a reaction to the Pentavalent
Varicella 1 year; Yes
YF 12-18 months; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2016-2020  2010-2014  2014-2019  2010-2014   
Nº of districts with microplans that include activities to raise immunization coverage number 1'122  1'122  1'122      80  1'123 

System performance

Total Nº districts in country number 1'122  1'122  1'122  1'122  1'122  1'122  1'123 
Nº districts with DTP3 coverage >=80% number 948  884  835  733  710  853  474 
% of districts with DTP3 coverage >=80% From 0 to 100% 84  79  74  65  63  76  42 
Nº districts with measles (MCV1) coverage >=95% number 494  441  400  310  393  480  288 
% of districts with MCV1 coverage >=95% From 0 to 100% 44  39  36  28  35  43  26 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.